The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.

This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.

View Congress Resources by Therapeutic Area
PLEASE NOTE: Materials will be available on a rolling basis after individual embargoes are lifted. Audio abstracts are generated using text-to-speech software and contain an audio version of the abstract that was submitted and accepted as part of the official conference materials.
Showing 6 of 39 results
Sort by date: Descending
Encores: Not included
World Sleep
September 5th – 10th 2025
Sleep-wake disorders
PRESENTATION
Vibrance-1: A Randomized Phase 2 Study Evaluating Safety and Efficacy of the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680) in Patients with Narcolepsy Type 1
AUTHOR(S)

Presented by Giuseppe Plazzi

View presentation
Listen to Audio Abstract
0:00 0:00
Sleep-wake disorders
Sleep-wake disorders
PRESENTATION
Improvement in the Severity of Narcolepsy Symptoms and Fatigue in Patients with Narcolepsy Type 1 Treated with the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680)
AUTHOR(S)

Presented by Yves Dauvilliers

View presentation
Listen to Audio Abstract
0:00 0:00
Sleep-wake disorders
Sleep-wake disorders
PRESENTATION
Improvement in Patient-reported Cognitive Functioning in Patients with Narcolepsy Type 1 Treated with the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680)
AUTHOR(S)

Presented by Giuseppe Plazzi

View presentation
Listen to Audio Abstract
0:00 0:00
Sleep-wake disorders
Research Society on Alcohol
June 21st – 25th 2025
Alcohol Use Disorder
POSTER
Use of Primary and Specialist Care Among Patients with Chronic Medical Conditions With or Without Comorbid Alcohol Use Disorder
AUTHOR(S)

Regina Grebla;1 Xin Zhao;2 Lucas Watterson;1 Allison Keshishian2

View poster
Listen to Audio Abstract
0:00 0:00
Alcohol Use Disorder
SLEEP (Annual Meeting of the Associated Professional Sleep Societies)
June 7th – 11th 2025
Sleep-wake disorders
POSTER
The Clinical and Humanistic Burden of Narcolepsy: Matched Analysis of US National Health and Wellness Survey Data
AUTHOR(S)

Kiran P. Maski,1 Michael J. Doane,2 M. Janelle Cambron-Mellott,3 Shakiba Eslamimehr,3 Adam Jauregui,3 Wilbur P. Williams, III2

View poster
Listen to Audio Abstract
0:00 0:00
Sleep-wake disorders
Sleep-wake disorders
POSTER
Vibrance-3: Study Design and Methods for a Phase 2, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of ALKS 2680 in Patients With Idiopathic Hypersomnia
AUTHOR(S)

David Plante,1 Ron Grunstein,2 Giuseppe Plazzi,3 Kiran Maski,4 Jandira Ramos,5 Yangchun Du,5 Alexandra Lovett,5 Marcus Yountz,5 Bhaskar Rege5

View poster
Listen to Audio Abstract
0:00 0:00
Sleep-wake disorders